Dr. Jatoi Direct Primary Care

Dr. Jatoi Direct Primary Care is a Direct Primary Care (DPC) clinic in Tucson Arizona. The clinic is based on a membership platform, where individuals can employ the services of the doctor on a per-month basis with a fixed fee instead of the old insurance system.

The concept focuses on intimate doctor-patient relationships, long-term care access, and 24/7 access. The services are same-day visits, telemedicine, and in-home visits. The clinic is also a LegitScript qualified one.

Besides the primary care, the practice includes a physician-based concierge medical weight loss program, which includes GLP-1 injections.

Healthcare Professionals

Dr. Mansoor Jatoi, DO
Founder and Physician

• Board Certified by the AOA Board of Internal Medicine
• Holds an Arizona State Medical License
• Graduate of Midwestern University Arizona College of Osteopathic Medicine (2012)
• Final residency at Canyon Vista Medical Center and was Chief Resident.
• About 14 years of clinical practice.
• Associated with Tucson Medical Center.
• Experience includes Hospital Medicine, Family Medicine, and Internal Medicine

Dr. Jatoi established his own Direct Primary Care practice after complaining about the primary care model based on insurance. His practice revolves around patient panels, longer patient stays, one-on-one interaction, and care in the home.

Services Offered

Direct Primary Care (DPC)

• 24/7 on-call medical access
• Direct communication via phone, text, email, and telemedicine
• Same-day appointments
• Home visits
• Flat plans of monthly subscriptions.

The DPC model will be used to remove the intricacies of insurance billing and offer direct physician access.

GLP-1 Weight Loss

• Lose pounds of fat every week
• Money Back Guarantee
• No membership or hidden fees! Everything you need is included
• Start for just $179, no insurance required + free shipping

GLP-1 for Just $179

100k MembersHSA/FSA ApprovedFrom $179

Medical Concierge Weight Loss Program

An individualized weight loss program with personalized follow-up using GLP-1 injections run by a physician.

The components of the program can be:

• Primary telemedicine consultation.
• Two months of doctor services.
• Eight weeks of concierge medical weight loss care.
• Direct access to Dr. Jatoi
• Tailored nutrition planning
• Constant observation and follow-up.

The program encourages a decrease in appetite and loss of weight. Among possible weight losses that the clinic mentions are:

• 15–25 pounds in two months
• 25–50 pounds or more in four months

Individual results vary.

GLP-1 Injections

Semaglutide (GLP-1)

• Applied as a component of the weight loss program.
• Compounded formulae can be used.
• It was meant to aid in suppression of appetite and cravings.

Tirzepatide

• Stated in case of GLP-1 insensitive patients.
• Granted in accordance with program requirements.

Availability of the medication may fluctuate according to the supply of the medication, as the site mentions.

Patient Reviews and Feedback

General patient feedback outlines Dr. Jatoi as:

• Knowledgeable
• Responsive
• Professional
• Caring and attentive
• Clear in explanations

Patients have noted prompt communication, often receiving same-day or within 24-hour responses. The models of extended access and telehealth options are often named as the positive attributes of the practice.

Pricing Overview

Direct Primary Care Membership

• In one section listed at $120 per month.
• There is another listing of $75 per month.

(Inconsistent price details are present on listings.)

Medical Concierge Weight Loss Program

• First two months and initial consultation with the physician: $185.
• Follow up package: $120 after every two months.
• Semaglutide (new start): $170 for 8 weeks of medication
• Tirzepatide (GLP-1 resistant patients): $525

The DPC model encourages possible savings in costs by direct access to physicians, fewer urgent care visits, and wholesale pricing of medication.

Consideration Notes

• There is contradictory information on pricing with regards to DPC membership fee.
• Certain listings show that the DPC program might not be taking in new general patients, whereas the weight loss program seems to be independent.
• The site observes that the supply may be limited and hence medication availability can be subject to supply.
• Compounded semaglutide is mentioned; patients need to know the difference between compounded and brand-name drugs.
• The site has a warning about the risk of thyroid C-cell tumors in connection with GLP-1 drugs and gives contraindications.
• As with any GLP-1 therapy, side effects and eligibility should be reviewed directly with the prescribing physician.